189 related articles for article (PubMed ID: 2063867)
1. DNA polymorphisms in the controlling region of the human haptoglobin genes: a molecular explanation for the haptoglobin 2-1 modified phenotype.
Maeda N
Am J Hum Genet; 1991 Jul; 49(1):158-66. PubMed ID: 2063867
[TBL] [Abstract][Full Text] [Related]
2. A base substitution in the promoter associated with the human haptoglobin 2-1 modified phenotype decreases transcriptional activity and responsiveness to interleukin-6 in human hepatoma cells.
Grant DJ; Maeda N
Am J Hum Genet; 1993 May; 52(5):974-80. PubMed ID: 8387722
[TBL] [Abstract][Full Text] [Related]
3. The haptoglobin-gene deletion responsible for anhaptoglobinemia.
Koda Y; Soejima M; Yoshioka N; Kimura H
Am J Hum Genet; 1998 Feb; 62(2):245-52. PubMed ID: 9463309
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the human haptoglobin gene cluster: chromosomes with multiple haptoglobin-related (Hpr) genes.
Maeda N; McEvoy SM; Harris HF; Huisman TH; Smithies O
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7395-9. PubMed ID: 2876426
[TBL] [Abstract][Full Text] [Related]
5. Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection.
Cox SE; Doherty C; Atkinson SH; Nweneka CV; Fulford AJ; Ghattas H; Rockett KA; Kwiatkowski DP; Prentice AM
PLoS One; 2007 Apr; 2(4):e362. PubMed ID: 17426810
[TBL] [Abstract][Full Text] [Related]
6. Duplication within the haptoglobin Hp2 gene.
Maeda N; Yang F; Barnett DR; Bowman BH; Smithies O
Nature; 1984 May 10-16; 309(5964):131-5. PubMed ID: 6325933
[TBL] [Abstract][Full Text] [Related]
7. The relationship between haptoglobin polymorphism and serum ceruloplasmin ferroxidase activity.
Janaydeh M; Hamad M; Awadallah S
Clin Exp Med; 2004 Apr; 3(4):219-23. PubMed ID: 15103512
[TBL] [Abstract][Full Text] [Related]
8. Haptoglobin 2-2 phenotype is a risk factor for type 2 diabetes in Ghana.
Quaye IK; Ababio G; Amoah AG
J Atheroscler Thromb; 2006 Apr; 13(2):90-4. PubMed ID: 16733296
[TBL] [Abstract][Full Text] [Related]
9. Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations.
Papp M; Foldi I; Nemes E; Udvardy M; Harsfalvi J; Altorjay I; Mate I; Dinya T; Varvolgyi C; Barta Z; Veres G; Lakatos PL; Tumpek J; Toth L; Szathmari E; Kapitany A; Gyetvai A; Korponay-Szabo IR
Clin Chem; 2008 Apr; 54(4):697-704. PubMed ID: 18258668
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis.
Vitalis Z; Altorjay I; Tornai I; Palatka K; Kacska S; Palyu E; Tornai D; Udvardy M; Harsfalvi J; Dinya T; Veres G; Lakatos PL; Papp M
Hum Immunol; 2011 Apr; 72(4):348-54. PubMed ID: 21262313
[TBL] [Abstract][Full Text] [Related]
11. A novel exonuclease (TaqMan) assay for rapid haptoglobin genotyping.
Renner W; Jahrbacher R; Marx-Neuhold E; Tischler S; Zulus B
Clin Chem Lab Med; 2016 May; 54(5):781-3. PubMed ID: 26479343
[TBL] [Abstract][Full Text] [Related]
12. Does haptoglobin genotype affect early onset of diabetic retinopathy in patients with type 2 diabetes?
Goldenberg-Cohen N; Gabbay M; Dratviman-Storobinsky O; Reich E; Axer-Siegel R; Weinberger D; Gabbay U
Retina; 2011 Sep; 31(8):1574-80. PubMed ID: 21555971
[TBL] [Abstract][Full Text] [Related]
13. Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.
Vormittag R; Vukovich T; Mannhalter C; Minar E; Schönauer V; Bialonczyk C; Hirschl M; Pabinger I
Haematologica; 2005 Nov; 90(11):1557-61. PubMed ID: 16266904
[TBL] [Abstract][Full Text] [Related]
14. Hp1-1 as a Genetic Marker Regulating Inflammation and the Possibility of Developing Diabetic Complications in Patients with Type 2 Diabetes-Cohort Studies.
Stempkowska A; Walicka M; Franek E; Naruszewicz M; Panczyk M; Sanchak Y; Filipek A
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114431
[TBL] [Abstract][Full Text] [Related]
15. Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage.
Hostettler IC; Morton MJ; Ambler G; Kazmi N; Gaunt T; Wilson D; Shakeshaft C; Jäger HR; Cohen H; Yousry TA; Al-Shahi Salman R; Lip G; Brown MM; Muir K; Houlden H; Bulters DO; Galea I; Werring DJ;
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):298-304. PubMed ID: 31924654
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum haptoglobin levels and Hp1-Hp2 polymorphism in the haptoglobin gene in patients with atrial fibrillation.
Costa LBX; Martins GL; Duarte RCF; Rocha PL; Figueiredo EL; Silveira FR; das Graças Carvalho M; Reis HJ; Gomes KB; Ferreira CN
Mol Biol Rep; 2022 Aug; 49(8):7359-7365. PubMed ID: 35576050
[TBL] [Abstract][Full Text] [Related]
17. Haptoglobin genotype and its relation to asymptomatic cerebral small-vessel disease in type 1 diabetes.
Eriksson MI; Syreeni A; Sandholm N; Dahlström EH; Gordin D; Tatlisumak T; Putaala J; Groop PH; Martola J; Thorn LM;
Acta Diabetol; 2023 Jun; 60(6):749-756. PubMed ID: 36856861
[TBL] [Abstract][Full Text] [Related]
18. TaqMan-based real-time PCR for genotyping common polymorphisms of haptoglobin (HP1 and HP2).
Soejima M; Koda Y
Clin Chem; 2008 Nov; 54(11):1908-13. PubMed ID: 18787013
[TBL] [Abstract][Full Text] [Related]
19. Reductive nitrosylation of ferric human hemoglobin bound to human haptoglobin 1-1 and 2-2.
Ascenzi P; De Simone G; Polticelli F; Gioia M; Coletta M
J Biol Inorg Chem; 2018 May; 23(3):437-445. PubMed ID: 29605886
[TBL] [Abstract][Full Text] [Related]
20. Haptoglobin levels are influenced by Hp1-Hp2 polymorphism, obesity, inflammation, and hypertension in type 2 diabetes mellitus.
Rodrigues KF; Pietrani NT; Carvalho LML; Bosco AA; Sandrim VC; Ferreira CN; Gomes KB
Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):99-107. PubMed ID: 30528492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
